EphrinA5 suppresses colon cancer development by negatively regulating epidermal growth factor receptor stability

Aberrant DNA methylation and epigenetic inactivation of Eph receptor tyrosine kinases and ephrin ligands in acute lymphoblastic leukemia

(2010) S.-Q. Kuang et al.   BLOOD

EGFR mutations and the terminal respiratory unit

(2010) Yasushi Yatabe   CANCER AND METASTASIS REVIEWS

The EphB6 Receptor Cooperates with c-Cbl to Regulate the Behavior of Breast Cancer Cells

(2010) L. Truitt et al.   CANCER RESEARCH

Increased epidermal growth factor receptor expression at the invasive margin is a negative prognostic factor in colorectal cancer

(2010) Ingrid Ljuslinder et al.   INTERNATIONAL JOURNAL OF CANCER

Of Ephs and Ephrins: Companies Target Guidance Molecules in Cancer

(2010) K. Garber   JNCI-Journal of the National Cancer Institute

Population-based differences in treatment outcome following anticancer drug therapies

(2010) Brigette BY Ma et al.   LANCET ONCOLOGY

The Evolving Role of Monoclonal Antibodies in Colorectal Cancer: Early Presumptions and Impact on Clinical Trial Development

(2010) C. Eng   ONCOLOGIST

EGFR Signaling and Drug Discovery

(2010) Georg Lurje et al.   ONCOLOGY

Cancer Statistics, 2009

(2009) A. Jemal et al.   CA-A CANCER JOURNAL FOR CLINICIANS

Cell adhesion and EGFR activation regulate EphA2 expression in cancer

(2009) Alice Bjerregaard Larsen et al.   CELLULAR SIGNALLING

Synapse development and plasticity: roles of ephrin/Eph receptor signaling

(2009) Kwok-On Lai et al.   CURRENT OPINION IN NEUROBIOLOGY

EGF receptor in relation to tumor development: molecular basis of responsiveness of cancer cells to EGFR-targeting tyrosine kinase inhibitors

(2009) Kenji Takeuchi et al.   FEBS Journal

Down-regulation of ephrin-A5, a gene product of normal cartilage, in chondrosarcoma

(2009) Thomas Kalinski et al.   HUMAN PATHOLOGY

Biomarkers Predicting Clinical Outcome of Epidermal Growth Factor Receptor–Targeted Therapy in Metastatic Colorectal Cancer

(2009) Salvatore Siena et al.   JNCI-Journal of the National Cancer Institute

Are RAS mutations predictive markers of resistance to standard chemotherapy?

(2009) Yohann Loriot et al.   Nature Reviews Clinical Oncology

EphrinA5 acts as a tumor suppressor in glioma by negative regulation of epidermal growth factor receptor

(2009) J-J Li et al.   ONCOGENE

Clinical Significance of Ephrin (Eph)-A1, -A2, -A4, -A5 and -A7 Receptors in Pancreatic Ductal Adenocarcinoma

(2009) Constantinos Giaginis et al.   PATHOLOGY & ONCOLOGY RESEARCH

Effects of dasatinib on EphA2 receptor tyrosine kinase activity and downstream signalling in pancreatic cancer

(2008) Q Chang et al.   BRITISH JOURNAL OF CANCER

Eph-Ephrin Bidirectional Signaling in Physiology and Disease

(2008) Elena B. Pasquale   CELL

Eph–ephrin signalling in adult tissues and cancer

(2008) Anna Merlos-Suárez et al.   CURRENT OPINION IN CELL BIOLOGY

Eph/ephrin signaling: networks

(2008) D. Arvanitis et al.   GENES & DEVELOPMENT

Genome-wide identification of aberrantly methylated promoter associated CpG islands in acute lymphocytic leukemia

(2008) S-Q Kuang et al.   LEUKEMIA

Bidirectional modulation of synaptic functions by Eph/ephrin signaling

(2008) Rüdiger Klein   NATURE NEUROSCIENCE